DPP-4 inhibitors × lipids

TrialJournal of diabetes investigation2017

Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function.

Fumika Shigiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

One number in the abstract

the abstract, start to end

only in the linagliptin add-on group (-6.0 ± 11.3 mg/dL, P < 0.01).

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Apolipoprotein Blinagliptin add-on group vs baseline
−6.0
DPP-4 inhibitorsLipids
1 / 3

23 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27868359